Roots Analysis has announced the addition of “Non-hormonal Therapies for Women’s Health Market ” report to its list of offerings.
In pursuit of an advantageous and risk-free prospect to hormonal therapies, the success of 21 approved non-hormonal therapies has resulted in a surge in the interest of drug developers in this rapidly evolving domain.
To order this 225+ page report, which features 92+ figures and 154+ tables, please visit https://www.rootsanalysis.com/reports/non-hormonal-therapies-for-women-health-market.html
Key Market Insights
Around 55 non-hormonal therapies are currently being developed across different stages
Apart from 21 approved products, close to 58% of the aforementioned candidates are being evaluated in clinical stages of development, with 2% of therapies in preclinical stages. It is worth mentioning that more than 80% of such drugs are small molecules. Further, majority of the therapies are being developed for the treatment of endometriosis (19%).
Over 64% of the non-hormonal therapy developers are based in North America
Interestingly, within the aforementioned region, majority of the players (21) are based in the US, which is considered a prominent R&D hub for advanced therapeutic products. Moreover, the current market is dominated by the presence of small players and very large firms, respectively.
220+ non-hormonal therapy focused clinical trials have been registered, worldwide
The clinical research activity, in terms of number of trials registered, is reported to have increased at a CAGR of 19% during the period 2015-2019. Of the total number of trials, close to 83% have already been completed, while 15% studies are presently active.
To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/non-hormonal-therapies-for-women-health-market/request-sample.html
You may also be interested in the following titles:
1. RNA Targeting Small Molecules Therapeutics Market: Industry Trends and Global Forecasts, 2021-2030
2. Top Selling Biologics Market: Industry Trends and Global Forecasts, 2021-2030
3. Peptide Therapeutics Market: Industry Trends and Global Forecasts, 2021-2030
Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
[email protected]
